L 753037

Known as: L-753,037 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2004
012319992004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SUMMARY Efficacy of a new, potent non-selective endothelin antagonist, l-753037, was examined in a model of canine coronary… (More)
Is this relevant?
2000
2000
The single oral administration of a mixed endothelin-A-and -B- (ETA/ETB) receptor antagonist, J-104132 (L-753,037) decreased the… (More)
Is this relevant?
1999
1999
The studies presented in this paper were undertaken to investigate the effects of L-753,037, a balanced endothelin receptor… (More)
Is this relevant?
1999
1999
J-104132 [(+)-(5S,6R, 7R)-2-butyl-7-[2-((2S)-2-carboxypropyl)-4-methoxyphenyl]-5-(3, 4-methylenedioxyphenyl)cyclopenteno[1,2-b… (More)
Is this relevant?
1999
1999
A liquid chromatographic/turbo ionspray tandem mass spectrometric (LC/MS/MS) method was developed and validated for the… (More)
Is this relevant?